Speech-induced cerebral metabolic activation reflects recovery from aphasia.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 9094051)

Published in J Neurol Sci on February 12, 1997

Authors

W D Heiss1, H Karbe, G Weber-Luxenburger, K Herholz, J Kessler, U Pietrzyk, G Pawlik

Author Affiliations

1: Max-Planck-Institut für neurologische Forschung, Köln, Germany.

Associated clinical trials:

Language Functional Reorganization in Subcortical Infarction Patients | NCT03668132

Articles citing this

Mechanisms of recovery from aphasia: evidence from positron emission tomography studies. J Neurol Neurosurg Psychiatry (1999) 2.18

Functional MRI of language in aphasia: a review of the literature and the methodological challenges. Neuropsychol Rev (2007) 1.68

Improved naming after TMS treatments in a chronic, global aphasia patient--case report. Neurocase (2005) 1.26

Neural signatures of semantic and phonemic fluency in young and old adults. J Cogn Neurosci (2009) 1.12

Recovery of function in humans: cortical stimulation and pharmacological treatments after stroke. Neurobiol Dis (2009) 1.09

Non-fluent aphasia and neural reorganization after speech therapy: insights from human sleep electrophysiology and functional magnetic resonance imaging. Arch Ital Biol (2010) 0.88

Distinct mechanisms and timing of language recovery after stroke. Cogn Neuropsychol (2014) 0.86

Aphasia severity: Association with cerebral perfusion and diffusion. Aphasiology (2002) 0.85

Preoperative mapping of cortical language areas in adult brain tumour patients using PET and individual non-normalised SPM analyses. Eur J Nucl Med Mol Imaging (2003) 0.85

Lesion characteristics related to treatment improvement in object and action naming for patients with chronic aphasia. Brain Lang (2009) 0.79

Language reorganization in aphasics: an electrical stimulation mapping investigation. Neurosurgery (2008) 0.77

Transcranial direct current stimulation in post-stroke sub-acute aphasia: study protocol for a randomized controlled trial. Trials (2016) 0.75

An intention manipulation to change lateralization of word production in nonfluent aphasia: current status. Semin Speech Lang (2008) 0.75

Maladaptive Plasticity in Aphasia: Brain Activation Maps Underlying Verb Retrieval Errors. Neural Plast (2016) 0.75

Articles by these authors

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer (1999) 8.29

GATE: a simulation toolkit for PET and SPECT. Phys Med Biol (2004) 7.88

DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry (2004) 2.91

The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr (1994) 2.88

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees. J Virol (1990) 2.65

Differential capacity of left and right hemispheric areas for compensation of poststroke aphasia. Ann Neurol (1999) 2.57

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology (2004) 2.07

Multiple nonprimary motor areas in the human cortex. J Neurophysiol (1997) 1.97

Cerebral representation of one's own past: neural networks involved in autobiographical memory. J Neurosci (1996) 1.97

Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain (2001) 1.93

Quantitative capillary topography and blood flow in the cerebral cortex of cats: an in vivo microscopic study. Brain Res (1981) 1.73

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry (2005) 1.69

11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology (1998) 1.56

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology (2005) 1.54

Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol (1996) 1.49

Ductus venosus shunting in growth-restricted fetuses and the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol (2006) 1.49

Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine. J Nucl Med (1991) 1.46

Bidirectional alterations of interhemispheric parietal balance by non-invasive cortical stimulation. Brain (2009) 1.46

Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr (1992) 1.43

Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42

Performance of a randomization test for single-subject (15)O-water PET activation studies. J Cereb Blood Flow Metab (1997) 1.40

Left hemispheric neuronal heterotopia: a PET, MRI, EEG, and neuropsychological investigation of a university student. Neurology (1994) 1.39

HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med (1994) 1.38

Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication. Proc Natl Acad Sci U S A (1999) 1.37

Quality of the family physician component of AMA Masterfile. J Am Board Fam Pract (1996) 1.34

Normal and pathological aging--findings of positron-emission-tomography. J Neural Transm (Vienna) (1998) 1.33

Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab (1992) 1.31

Impaired episodic memory retrieval in a case of probable psychogenic amnesia. Psychiatry Res (1997) 1.29

GATE V6: a major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy. Phys Med Biol (2011) 1.29

Brain plasticity in poststroke aphasia: what is the contribution of the right hemisphere? Brain Lang (1998) 1.24

Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia (1994) 1.22

Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology (2008) 1.21

Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand (2004) 1.18

Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dement Geriatr Cogn Disord (2009) 1.18

Plasticity of language networks in patients with brain tumors: a positron emission tomography activation study. Ann Neurol (2001) 1.17

Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol (2006) 1.16

The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations. J Med Primatol (1989) 1.15

Disturbance and recovery of language function: correlates in PET activation studies. Neuroimage (2003) 1.15

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. Br J Cancer (2001) 1.13

Cerebral blood flow and metabolism during cardiopulmonary bypass: evidence of microembolic encephalopathy. Neurology (1971) 1.13

CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. Eur J Neurol (2008) 1.10

Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.10

Vascular dementia: perfusional and metabolic disturbances and effects of therapy. J Neural Transm Suppl (1996) 1.09

An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med (1994) 1.08

Molecular recognition of tRNA(Pro) by Escherichia coli proline tRNA synthetase in vitro. Nucleic Acids Res (1995) 1.07

Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [¹⁸F]-IL1RA and PET imaging in rats. Br J Pharmacol (2011) 1.07

A comparison of unawareness in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2007) 1.06

The production of microemboli by various blood oxygenators. Ann Thorac Surg (1970) 1.06

Microemboli during cardiopulmonary bypass detected by ultrasound. Surg Gynecol Obstet (1969) 1.05

The amygdala's contribution to memory--a study on two patients with Urbach-Wiethe disease. Neuroreport (1994) 1.04

Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment. Dement Geriatr Cogn Disord (2005) 1.03

Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology (1993) 1.01

Early [(11)C]Flumazenil/H(2)O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke (2000) 1.01

Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg (1993) 1.01

In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol (1992) 1.00

Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab (1984) 1.00

Robustness of multivariate image analysis assessed by resampling techniques and applied to FDG-PET scans of patients with Alzheimer's disease. Neuroimage (2009) 1.00

Impact of alertness training on spatial neglect: a behavioural and fMRI study. Neuropsychologia (2005) 1.00

Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol (1994) 1.00

Preoperative activation and intraoperative stimulation of language-related areas in patients with glioma. Neurosurgery (1997) 0.99

Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology (2000) 0.99

Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology (1990) 0.99

EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force. Eur J Neurol (2006) 0.99

Preictal SPECT in temporal lobe epilepsy: regional cerebral blood flow is increased prior to electroencephalography-seizure onset. J Nucl Med (1998) 0.98

Linking retinotopic fMRI mapping and anatomical probability maps of human occipital areas V1 and V2. Neuroimage (2005) 0.98

Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study. J Neural Transm (Vienna) (2003) 0.98

Clinical applications of registration and fusion of multimodality brain images from PET, SPECT, CT, and MRI. Eur J Radiol (1996) 0.98

Cerebral metabolic correlates of four dementia scales in Alzheimer's disease. J Neurol (2005) 0.97

A functional magnetic resonance imaging study of local/global processing with stimulus presentation in the peripheral visual hemifields. Neuroscience (2004) 0.97

Induced sputum improves the diagnosis of pulmonary tuberculosis in hospitalized patients in Gaborone, Botswana. Int J Tuberc Lung Dis (2008) 0.97

Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab (1998) 0.97

Alterations of neuropsychological function and cerebral glucose metabolism after cardiac surgery are not related only to intraoperative microembolic events. Stroke (1998) 0.96

Learning face-name associations and the effect of age and performance: a PET activation study. Neuropsychologia (2001) 0.96

Localization of language-related cortex with 15O-labeled water PET in patients with gliomas. Neuroimage (1998) 0.96

Long-term results of carpal tunnel decompression. Assessment of 60 cases. J Hand Surg Br (1993) 0.96

Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming. Brain Res (1985) 0.95

PET-based molecular imaging in neuroscience. Eur J Nucl Med Mol Imaging (2003) 0.95

Regional cerebral blood flow in man at rest and during exercise. J Neurol (1987) 0.95